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Ion transporters play an important role in several physiological functions, such as cell
volume regulation, pH homeostasis and secretion. In the oesophagus, ion transport
proteins are part of the epithelial resistance, a mechanism which protects the
oesophagus against reflux-induced damage. A change in the function or expression
of ion transporters has significance in the development or neoplastic progression
of Barrett’s oesophagus (BO). In this review, we discuss the physiological and
pathophysiological roles of ion transporters in the oesophagus, highlighting transport
proteins which serve as therapeutic targets or prognostic markers in eosinophilic
oesophagitis, BO and esophageal cancer. We believe that this review highlights
important relationships which might contribute to a better understanding of the
pathomechanisms of esophageal diseases.
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INTRODUCTION
Ion and water transport play a crucial role in the development of gastrointestinal (GI) diseases, such
as cystic fibrosis or diarrhea. Therefore, a number of studies have been conducted to identify the
presence and function of transport proteins on GI cells, especially in exocrine glands, the stomach
and the colon (Toth-Molnar et al., 2007; Venglovecz et al., 2008, 2011; Farkas et al., 2011; Hegyi
et al., 2011; Czepan et al., 2012; Judak et al., 2014) both under physiological and pathophysiological
conditions. In contrast, the literature on ion transport in the oesophagus is limited. The oesophageal
epithelium (OE) is built up from squamous epithelial cells (SECs) arranged in stratified layers.
Although the OE is not a typical secretory epithelium, its ion transport processes are of great
importance with regard to epithelial resistance (Orlando, 1986; Goldstein et al., 1994; Gunther et al.,
2014). OE resistance is an important defense mechanism which prevents cells from reflux-induced
acidosis (Fujiwara et al., 2005). OE resistance involves a number of factors, such as ion transport
processes through apical and basolateral membranes. Disturbances of oesophageal ion transport
might play a role in certain pathological conditions, such as eosinophilic oesophagitis (EoO),
Barrett’s oesophagus (BO) and oesophageal cancer (OC). This review summarizes our knowledge of
the expression and function of oesophageal ion transporters and elucidates their role in oesophageal
diseases. We believe that this review highlights important relationships which might contribute to
a better understanding of the pathomechanisms of oesophageal diseases.
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STRUCTURE OF THE OESOPHAGUS
The oesophagus consists of four layers, namely the mucosa,
submucosa, muscularis externa, and adventitia. Epithelial cells
are located in the mucosa and submucosa layers. The mucosa
layer is composed of squamous epithelial cells arranged in several
rows. There are differences in the thickness and keratinization
of the mucosa between species (Figure 1). In the oesophagus
of rodents, squamous cells are arranged to 4 to 5 layers and are
typically keratinised. In humans and pig’s oesophagus, squamous
cells are located in several layers, up to 10–15, and the cells are not
keratinised. The submucosa layer contains connective tissue cells,
blood and lymphatic vessels, nerves, and glands. Interestingly,
there are no glands in the oesophagus of rodents, while they
occur in large numbers in the oesophagus of humans and pigs.
The submucosal glands (SMGs) are tubuloacinar glands that
occur scattered throughout the submucosa. SMGs secrete mainly
mucus, HCO3− and growth factors, and their primary function is
to lubricate the oesophagus and to protect it from the damaging
effects of the refluxed acid. The submucosa layer is followed by
the muscular externa that is composed of smooth and striated
muscle, while adventitia is mostly composed of connective and
adipose tissue. Ion mechanisms on SECs have been primarily
studied in rabbit, whereas pigs proved to be a suitable animal
model for studying ion transport processes associated with SMGs.
The next section describes the ion transporters so far identified
on SECs and SMGs.
PRESENCE AND ROLE OF ION
TRANSPORTERS UNDER
PHYSIOLOGICAL CONDITIONS
Cl− Channels
Chloride (Cl−) transport is essentially a two-step process
that involves the entry of Cl− into the cell across the
basolateral membrane and its secretion into the lumen through
the apical membrane (Frizzell and Hanrahan, 2012). These
processes involve various transport proteins, of which Cl−
is usually taken up by cells through the Na+/K+/2Cl− co-
transporter (NKCC) and released to the lumen through the
cystic fibrosis transmembrane conductance regulator (CFTR).
Epithelial Cl− transport provides an electrical driving force
for the paracellular transport of Na+ from the basolateral
side to the lumen. As a result, the osmotic pressure in the
lumen increases, which promotes the movement of water into
the lumen (Frizzell and Hanrahan, 2012). Oesophageal Cl−
transport in the squamous epithelium and SMGs was mainly
investigated by Abdulnour-Nakhoul et al. (2002) (Tables 1, 2).
Using isolated rabbit OE, they showed the presence of Cl−
conductance at both the basolateral and the apical membrane of
oesophageal epithelial cells (OECs) (Abdulnour-Nakhoul et al.,
2002). The basolateral Cl− conductance was Ca2+-dependent
and flufenamate-sensitive. However, the CFTR activator, cyclic
adenosine monophosphate (cAMP), or the anion exchanger
(AE) inhibitor, 4,4′-diisothiocyano-2,2′-stilbenedisulfonic acid
(DIDS), did not affect Cl− conductance. In addition, Cl−
transport was independent of the presence of extracellular
HCO3−, indicating that basolateral Cl− conductance is believed
to be a Ca2+-activated Cl− channel (CaCC). In contrast, apical
Cl− conductance played only a minor role in Cl− transport
indicating that there is no significant transcellular Cl− transport
across squamous cells. Transcellular Cl− transport has greater
importance in SMGs, where fluid secretion is more significant.
Apical Cl− transport in SMGs can be linked to the CFTR
Cl− channel (Abdulnour-Nakhoul et al., 2011). Using different
approaches, the CFTR has been detected in the acinar cells and
at the apical membrane of intra- and interlobular ductal cells of
pig oesophageal SMGs. In addition, using different activators and
inhibitors it has been demonstrated that the CFTR Cl− channel
is functionally active and is expected to be involved in HCO3−
secretion in two ways: the CFTR (i) changes its permeability
and secretes HCO3− directly into the lumen and (ii) provides
extracellular Cl− for the function of the apical Cl−/HCO3−
exchanger, similarly, to the pancreas or the salivary gland (Lee
et al., 2012). The transcellular transport of Cl− is mediated by the
basolateral AE2, through which Cl− enters the cell.
K+ Channels
Potassium (K+) channels have an extensive family, which
includes voltage-dependent K+ channels, Ca2+-activated K+
channels, or ATP-regulated K+ channels (Heitzmann and Warth,
2008). Epithelial K+ channels can be found on both the
basolateral and luminal membranes of the epithelial cells where
they serve different functions. Voltage-dependent K+ channels
are usually expressed on the basolateral membrane, where they
determine the membrane potential of the cell, provide an
electrochemical driving force for the transport of other ions,
such as Na+ or Cl− and also play a role in the recycling of K+
or the regulation of cell volume (Cotton, 2000). K+ channels
on the apical membrane mediate the secretion of K+ into the
lumen and therefore determine the K+ concentration of the
secreted fluid. Using chamber studies have shown the presence
of K+ conductance at the basolateral membrane of rabbit OECs
(Goldstein et al., 1993; Khalbuss et al., 1993). The K+ channel
is active under basal conditions and regulates transepithelial
Na+ uptake and cell volume after osmotic stress. The basolateral
K+ channel has also been shown to be important in regulatory
volume decrease (RVD) in isolated rabbit oesophageal cells and
human OECs (Snow et al., 1993; Orlando et al., 2002). RVD plays
role in the restitution of cell volume after an osmotic swelling. In
most cases, RVD is mediated through the efflux of K+ and Cl−
through the basolateral membrane, followed by water transport.
Snow et al. (1993) confirmed the significance of K+ efflux in
RVD and also showed that acidic pH inhibits K+ channel activity,
indicating that reduced RVD is probably involved in the reflux-
induced oesophageal injury. In addition, using pharmacological
inhibitors (e.g., DIDS and diphenylamine-2-carboxylate) or
intracellular Cl− removal, the authors showed that RVD also
depends on Cl− efflux (Snow et al., 1993). Orlando et al. (2002)
made similar observations in human oesophageal cells, with the
difference that they also identified a later, second mechanism
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FIGURE 1 | Histological comparison of rodent and human/pig oesophagus. The most common difference between rodent and human/pig oesophagus is that in
rodents the mucosa layer is thinner and the lack of submucosal glands. SMG, submucosal gland.
underlying RVD regulation: using R(+)-butylindazone, a KCl co-
transporter (KCC) inhibitor, they detected late RVD inhibition
(Orlando et al., 2002). KCC is an electroneutral transporter that
mediates the coupled transport of 1 K+ and 1 Cl− for which
the energy is provided by the K+ gradient maintained by the
Na+/K+ ATPase pump (Haas and Forbush, 1998, 2000). The
KCC family has four isoforms (KCC1-4) which show high levels
of homology in their amino acid sequence. Although KCC1
ubiquitously expressed, the presence of KCC2 and -3 mainly
limited to the nervous system. Abnormal regulation of KCC genes
leads to the development of hematological diseases such as sickle
cell anemia, which causes cellular dehydration in red blood cells
(Rees et al., 2015). In the oesophagus, K+ and Cl− transport
across the basolateral membrane of SECs present a protective
mechanism by which cells try to maintain the cell volume against
hypo-osmotic shock under acidic pH which has a significance in
reflux disease (Table 1).
Na+/K+/2Cl− Co-Transporter
The Na+/K+/2Cl− co-transporter (NKCC) mediates the
electroneutral uptake of 1 Na+, 1 K+ and 2 Cl− ions across
the plasma membrane (Russell, 2000). The NKCC has two
isoforms in humans (NKCC1 and NKCC2), which are encoded
by two different genes (SLC12A1 and SLC12A2). The NKCC is
primarily located on the basolateral membrane of various cells
and plays a role in several physiological functions, such as fluid
secretion in exocrine glands (Haas and Forbush, 2000) smooth
muscle cell contraction (Akar et al., 2001) and early neuronal
development (Ben-Ari et al., 2007). In most cells, NKCC interacts
with KCC. The effect of the two transporters is opposite. KCC
mediates Cl− efflux, whereas NKCC promotes the uptake of Cl−.
The coordinated operation of the two transporters ensures the
proper Cl− concentration in the cell. NKCC activity is greatly
influenced by intracellular Cl− concentration, which acts as a
negative feedback mechanism (Rocha-Gonzalez et al., 2008).
The mechanism by which cytoplasmic Cl− regulates NKCC is
not fully understood, but probably Cl− is able to modify the
phosphorylated state of the cotransporter. Loss of function
mutations of NKCC2 leads to the development of type 1 Bartter’s
syndrome, in which the reabsorption of salt is reduced in the
thick ascending limb of Henle’s loop (Castrop and Schiessl,
2014). In oesophageal SECs, the NKCC is primarily involved
in cell volume regulation (Tobey et al., 1995). Functional
studies on rabbit OE have shown that bumetanide-sensitive
Na+/K+/Cl− transport is activated by acidic pH, is linked to
the NKCC and induces cell oedema by ion uptake (Tobey et al.,
1995). K+ and Cl− conductances work in opposite directions
and promote cell shrinkage. NKCC1 is present in the human
oesophagus, in the lower and middle layers of squamous cells
(Shiozaki et al., 2014a). The NKCC is also present in SMGs,
where it plays an essential role in fluid secretion (Abdulnour-
Nakhoul et al., 2011). Immunostaining of pig oesophagus
shows strong, positive staining against NKCC1 antibody on
the basolateral membrane of mucous cells and interlobular
Frontiers in Physiology | www.frontiersin.org 3 July 2020 | Volume 11 | Article 855
fphys-11-00855 July 16, 2020 Time: 11:16 # 4
Becskeházi et al. Ion Transport in the Osophagus
TABLE 1 | Expression of ion transporters in oesophageal squamous epithelial cells (SECs).
Ion transporters in oesophageal squamous epithelial cells (SECs)
Family Type or isoform Physiological role Localization Species References
Cl− channel CaCC Regulates intracellular Cl−
concentration
Basolateral Rabbit Abdulnour-Nakhoul et al., 2002
K+ channel N/A Regulates transepithelial Na+ uptake
and cell volume and also modulates
RVD by K+ efflux
Basolateral Rabbit Goldstein et al., 1993; Khalbuss et al.,
1993; Snow et al., 1993
Human Orlando et al., 2002
KCC N/A Secondary regulatory mechanism of
RVD
Basolateral Human Orlando et al., 2002
NKCC NKCC1 Operates at acidic pH and regulates
cell volume
N/A Rabbit Tobey et al., 1995
NHE NHE1 Causes cellular alkalisation by extruding
H+ out of the cells
Basolateral Rabbit Powell et al., 1975; Layden et al., 1990,
1992; Abdulnour-Nakhoul et al., 1999;
Shallat et al., 1995
Rat Shallat et al., 1995
Human Goldman et al., 2010; Guan et al.,
2014; Laczko et al., 2016; Ariyoshi
et al., 2017
AE Na+-dependent Causes cell alkalisation, mediates Na+,
Cl− and HCO3− transport through the
plasma membrane
Basolateral Rabbit Bonar and Casey, 2008; Tobey et al.,
1993
Na+-independent Causes cell acidification, mediates Cl−
and HCO3− transport through the
plasma membrane
non-selective cation channel ENaC (?) Equally permeable for monovalent
cations (Li+, Na+ and K+), the exact
role is not known
Apical Rabbit Awayda et al., 2004
AE, anion exchanger; CaCC, Ca2+-activated Cl− channel; KCC, KCl co-transporter; NKCC, Na+/K+/2Cl− co-transporter; NHE, Na+/H+ exchanger; RVD, regulatory
volume decrease; N/A, not available.
TABLE 2 | Expression of ion transporters in oesophageal submucosal glands (SMGs).
Ion transporters in oesophageal submucosal glands (SMGs)
Family Type or isoform Physiological role Localization Species References
Cl− channel CFTR Contributes to luminal HCO3− secretion Apical Pig Abdulnour-Nakhoul et al., 2011
NKCC NKCC1 Regulates cell volume and provides Cl− for HCO3− secretion Basolateral
AE AE2 Facilitates the influx of Cl− and the efflux of HCO3− Basolateral
SLC26A6 Mediates HCO3− transport into the lumen Apical
NBC NBC1 Contributes to luminal HCO3− transport Basolateral Abdulnour-Nakhoul et al., 2005, 2011
AE, anion exchanger; CFTR, cystic fibrosis transmembrane conductance regulator; NBC, Na+/HCO3− co-transporter; NKCC, Na+/K+/2Cl− co-transporter.
ducts. Bumetanide, a specific NKCC1 inhibitor, inhibits HCO3−
secretion, indicating that NKCC1 is involved in the process,
presumably by providing the Cl− necessary for HCO3− secretion
(Abdulnour-Nakhoul et al., 2011).
Na+/H+ Exchangers
Na+/H+ exchangers (NHEs) are electroneutral exchangers with a
stoichiometry of 1 Na+:1 H+. For the transport of Na+ and H+,
NHEs use the energy that is provided by the electrochemical Na+
gradient maintained by the Na+/K+-ATPase. The N-terminal
membrane domain of the exchanger is responsible for the
transport of ions, whereas NHE is regulated through the
C-terminal cytoplasmic domain (Slepkov et al., 2007). NHEs
are involved in a wide range of biological functions, such as
cell proliferation (Grinstein et al., 1989) cell migration (Denker
et al., 2000) and cell volume regulation (Demaurex and Grinstein,
1994). One of their most important roles is cell alkalisation
via mediating the exchange of intracellular H+ for extracellular
Na+. Excess Na+ is removed from the cell by the Na+/K+-
ATPase and Na+/Ca2+ exchanger (Slepkov et al., 2007). NHEs
are encoded by the SLC9A gene family, which includes nine
members (NHE1–NHE9). NHE1 is ubiquitously expressed, while
the other isoforms are restricted to a specific tissue. Abnormal
function of NHEs is associated with a number of neurological
and cardiac diseases (Donowitz et al., 2013). Most NHEs are
activated by acidification (Lacroix et al., 2004) and can be blocked
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by amiloride (Kleyman and Cragoe, 1988). Early micro-electrode
studies on rabbit oesophagus have described an amiloride-
sensitive short-circuit current at the serosal and mucosal sides
of the oesophagus (Powell et al., 1975). Subsequently, the
presence of a Na+/H+ exchange mechanism was proved by
Layden et al. (1990). They identified a Na+-dependent, alkalizing
transport system in rabbit oesophageal cells which was sensitive
to amiloride and was activated at physiological pH ranges
(Layden et al., 1990). Further functional studies have confirmed
the presence of NHEs in rabbits (Layden et al., 1992; Abdulnour-
Nakhoul et al., 1999) and humans (Tobey et al., 1998) where pHi
regeneration depends on extracellular Na+ and occurs through
the basolateral membrane (Abdulnour-Nakhoul et al., 1999).
Reverse transcription-polymerase chain reaction (RT-PCR) and
immunoblot analysis confirm the presence of NHE1 in rat and
rabbit oesophageal cells (Shallat et al., 1995). Taken together these
data suggest that NHE1 is present on the basolateral membrane of
rodent oesophageal cells, where it is likely to regulate the pHi and
protect cells against reflux-induced acidity by extruding H+ out
of the cells. In contrast, results on NHE1 expression and function
in humans are somewhat contradictory. Immunohistochemical
(IHC) studies on human oesophageal tissue specimens have
shown the absence or weak expression of NHE1 in normal
squamous mucosa (Goldman et al., 2010; Guan et al., 2014;
Laczko et al., 2016; Ariyoshi et al., 2017), while functional assays
performed on the human oesophageal cell line and primary
cultures detect a high degree of NHE activity (Tobey et al., 1998;
Fujiwara et al., 2005). Even if NHE is present on OECs under
normal conditions, the role of NHE in the oesophagus is much
more important under pathological conditions as detailed below.
Cl−/HCO3− Exchangers and Na+/HCO3−
Co-Transporters
Cl−/HCO3− exchangers or AEs mediate Cl− and HCO3−
transport through the plasma membrane (Bonar and Casey,
2008). AEs either alkalise or acidify cells, depending on the
direction of HCO3− transport. The AE family comprises a large
number of transporters, which are encoded by two gene families
(SLC4A and SLC26A) (Bonar and Casey, 2008). The SLC4A
family comprises three transporter types: Na+/HCO3− co-
transporters (NBCs), Na+-dependent Cl−/HCO3− exchangers
(NDCBE and NCBE) and Na+-independent Cl−/HCO3−
exchangers (AE1, AE2, and AE3). Five members of the SLC26A
family (SLC26A3, SLC26A4, SLC26A6, SLC26A7, and SLC26A9)
differ most in their different Cl−: HCO3− stoichiometry and
therefore in their electrogenicity. AE family members differ in
many aspects, such as tissue expression, cell surface localization
and physiological function. Abnormal expression of SLC26A2-4
genes associated with rare, recessive diseases, such as diastrophic
dysplasia, congenital chloride diarrhea or Pendred syndrome,
respectively (Kere, 2006).
Two types of AE are found in oesophageal SECs (Tobey
et al., 1993): a Na+-dependent AE and a Na+-independent
Cl−/HCO3− exchanger. Although both transporters are
electroneutral, their effects are opposite. The Na+-dependent
AE plays an important role in cell alkalisation, along with the
NHE, while the Na+-independent AE acidifies cells, preventing
over-alkalisation. Na+-independent AEs mediate the exchange
of 1 Cl− for 1 HCO3−, while Na+-dependent AEs transport
Na+, in addition to HCO3− and Cl−. Both Na+-dependent and
Na+-independent AEs localize to the basolateral membrane and
conduct HCO3− transport from or toward the blood (Layden
et al., 1992; Tobey et al., 1993). Oesophageal HCO3− secretion
is much more related to SMGs (Abdulnour-Nakhoul et al.,
2005, 2011). A basal and carbachol-stimulated movement of
HCO3− was detected which was inhibited by DIDS in perfused
pig oesophagus. IHC staining showed the presence of an NBC
and AE2 on intra- and interlobular ducts and serous demilunes,
indicating that HCO3− secretion is probably due to these two
transporters. These transporters are localized to the basolateral
membrane of ductal cells, and they presumably provide HCO3−
and Cl− for luminal HCO3− secretion (Abdulnour-Nakhoul
et al., 2011). In contrast, at the luminal membrane of interlobular
ducts, studies have shown the messenger RNA (mRNA) and
protein expression of Slc26A6, which mediate HCO3− transport
into the lumen, in cooperation with the CFTR Cl− channel
(Abdulnour-Nakhoul et al., 2011). Luminal HCO3− secretion
is believed to protect the ooesophagus by neutralizing the
acidic refluxate.
Other Ion Transporters
Awayda et al. (2004) identified non-selective cation conductance
at the apical membrane of rabbit OECs which is equally
permeable to monovalent cations, such as Li+, Na+, and K+
(Awayda et al., 2004). In addition, western blotting showed
that this non-selective cation channel contains all three sub-
groups of the epithelial Na channel (ENaC), in both native
rabbit OE and HET-1A cells, although it does not have the
characteristics of epithelial Na+ channels and is not inhibited
by amiloride. The ENaC mediates cation uptake, although its
exact function is unknown. In addition, similarly, to other
epithelial cells, the Na+ gradient across the basolateral membrane
is maintained by Na+/K+-ATPase whose presence has been
detected on both squamous cells (Orlando et al., 1981, 1984) and
on the basolateral membrane of acini and ductal cells of SMGs
(Abdulnour-Nakhoul et al., 2011).
Figure 2 shows the presence and localization of ion
transporters on rabbit SECs (Figure 2A) and pig SMGs
(Figure 2B). In the case of SECs, transporters are mainly
localized to the basolateral membrane, and their primary role
is to increase the resistance of these cells to acidic reflux
by restoring changes in cell volume and intracellular pH. In
contrast, apical and basolateral ion transporters on SMGs are
primarily involved in HCO3− secretion, which is secreted into
the lumen via the SLC26a6 AE on the apical membrane of
intra-interlobular ducts. The secreted HCO3− neutralizes the
acidic gastric contents thereby largely prevents the diffusion of
the proton into the oesophageal tissue. In conclusion, under
physiological conditions, ion transport processes through the
SECs and SMGs represent an important defense mechanism
that protects the lower layers against the harmful effect of
acidic GI contents. Inadequate or altered function of these
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FIGURE 2 | The presence and localization of ion transporters on squamous epithelial cells (SECs) and submucosal glands (SMGs). The schematic diagram shows a
rabbit SEC (A) and a ductal cell of pig SMG (B). AE, anion exchanger; CA, carbonic anhydrase; CaCC, Ca2+-activated Cl- channel; CFTR, cystic fibrosis
transmembrane conductance regulator; KCC, KCl co-transporter; NBC, Na+/HCO3- co-transporter; NHE, Na+/H+ exchanger; NKCC, Na+/K+/2Cl- co-transporter.
transporters plays a role in the development and/or progression
of oesophageal diseases, such as EoE, BO or OC.
ROLE OF ION TRANSPORTERS UNDER
PATHOLOGICAL CONDITIONS
Eosinophilic Oesophagitis
Eosinophilic oesophagitis is a chronic inflammatory disease
induced by food antigens (Furuta and Katzka, 2015). EoE
is characterized by basal zone hyperplasia (BZH), dilated
intercellular spaces (DISs) and the filtration of eosinophilic
granulocytes into the oesophageal mucosa (Collins, 2008).
Interleukin 13 (IL-13) plays a major role in EoE pathology.
IL-13 is highly up-regulated in inflamed tissue and regulates
the expression of several key molecules (Blanchard et al.,
2010). Studies have reported altered expression of two ion
transporters [NHE3 and anoctamin 1 (ANO1)] in EoE (Zeng
et al., 2018; Vanoni et al., 2020). The mRNA and protein
expression of both NHE3 and ANO1 significantly increases
in biopsy samples obtained from EoE patients and in IL-13-
treated OECs and model systems. Both NHE3 and ANO1 are
up-regulated by the transcription factor signal transducer and
activator of transcription 6 (STAT6) and are positively correlated
with disease progression (Zeng et al., 2018; Vanoni et al.,
2020). Pharmacological NHE3 inhibition blocks IL-13-induced
DIS formation, indicating the involvement of NHE3 in DIS
formation (Zeng et al., 2018). NHE3 mediates the exchange of
intracellular H+ with extracellular Na+. Proton accumulation in
the intercellular space creates osmotic conditions which favor
water transport and, as a result, DIS formation (Zeng et al., 2018).
In contrast to NHE3, increased ANO1 expression is associated
with BZH (Vanoni et al., 2020). ANO1 is an apical Ca2+-
activated Cl− channel which is also permeable to HCO3–(Jung
et al., 2013). Application of ANO1 inhibitor or short hairpin
RNA (shRNA) shows that this Cl− channel interacts with cell
cycle regulatory proteins, such as TP63 and phosphorylated
cyclin-dependent kinase 2 (p-CDK2), thereby enhancing cell
proliferation. In addition, Cl− efflux through ANO1 likely plays a
role in intracellular Cl− depletion, which is a prerequisite for cell
division. These results indicate that both NHE3 and ANO1 are
part of the IL-13-mediated transcriptional cascade, which leads
to the histopathological features of EoE. Therefore, inhibition of
these transporters could be a potential therapeutic target for EoE
treatment (Vanoni et al., 2020).
Gastro-Oesophageal Reflux Disease and
Barrett’s Oesophagus
Barrett’s oesophagus is a condition in which the normal
squamous epithelium is replaced by columnar cells (Spechler and
Souza, 2014). It is the result of long-term gastro-oesophageal
reflux disease (GERD) and a type of adaptation to the altered
environment (Spechler and Souza, 2014). Many factors play
a role in BO development, although the exact underlying
mechanism is unclear. Several studies have been conducted in
which normal epithelial cells were exposed to acidic pH, bile
acids or a combination of the two and molecular changes and
cell survival were investigated. Lin et al. (2008) identified DIDS-
and ethyl-isopropyl amiloride (EIPA)-sensitive and HCO3−-
dependent transport mechanisms in rat oesophageal tissue upon
HCl administration, indicating the involvement of an NHE and
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one of the SLC26 AEs in the stimulatory effect of HCl (Lin
et al., 2008). Increased ionic movement due to acid exposure
is likely a protective mechanism and might play a role in the
GERD pathomechanism. Acidic pH decreases cell viability and
increases reactive oxygen species production in normal OECs, in
which NHE1 plays a protective role (Park et al., 2015). Similar
results have been found in human oesophageal cell lines, in
which the cytoprotective effect of epidermal growth factor against
acid-induced cell damage is mediated by NHE1 through the
Ca2+/calmodulin and protein kinase C (PKC) pathway (Fujiwara
et al., 2005). Increased NHE1 expression is found in oesophagitis,
GERD and BO, although it is unclear whether increased NHE1
levels are the consequence or the cause of these diseases
(Siddique and Khan, 2003; Fujiwara et al., 2005; Goldman et al.,
2010; Laczko et al., 2016). According to Siddique and Khan
(2003) NHE1 is involved in GERD development, presumably by
acidifying the extracellular space (Siddique and Khan, 2003). The
authors also found that in patients taking H2 receptor blockers,
the mRNA level of NHE1 is significantly lower compared to
untreated or antacid-treated GERD patients, assuming a specific
interaction between NHE1 and the histamine receptor in GERD.
In contrast, the increased NHE1 expression in BO is more likely
part of a defense or adaptive mechanism which protects cells
against acid reflux (Goldman et al., 2010). This hypothesis is also
supported by another study in which bile treatment alone or in
combination with acid increased NHE1 expression in metaplastic
(CP-A) and dysplastic (CP-D) oesophageal cell lines (Laczko
et al., 2016). Interestingly, NHE activity decreased in CP-A as
a result of treatment but increased in CP-D cells in a dose-
dependent manner. The reason probably is that CP-D cells are
in a more advanced state and are more frequently exposed to
acid or biliary reflux under pathological conditions. In addition
to NHE1, NHE2, NBC, and Slc26a6 expression also increased in
intestinal and non-intestinal metaplasia, which probably further
enhances cellular resistance against reflux-induced cell damage
(Laczko et al., 2016). These results suggest that increased NHE
expression found in BO is essentially a defense mechanism by
which metaplastic tissue tries to adapt to the altered environment.
Inhibition of the transporter promotes tumorigenesis because of
a decrease in intracellular pH.
Transient receptor potential channels (TRP) is a multifamily
of integral membrane proteins that found on several tissues
and cell types in animals (Nilius and Owsianik, 2011). TRP
channels function as non-selective cation channels and are
permeable to Na+; Ca2+ and Mg2. The TRP family can be
subdivided into seven subfamilies: TRPC (canonical), TRPV
(vanilloid), TRPM (melastatin), TRPP (polycystin), TRPML
(mucolipin), TRPA (ankyrin), and TRPN (NOMPC-like). These
channels mediate a wide range of physiological functions, such as
sensations of temperature, pain, tastes, vision, olfaction, hearing
and intracellular ion homeostasis. Some TRP channels act as
a thermo-; osmolarity- or voltage sensor, and some of them
activated by membrane stretch or cytoplasm volume changes.
The activated TRP channels cause depolarisation of the cell
membranes, which is essential in the development of action
potential in excitable cells (Nilius and Owsianik, 2011). The
role of the TRP channels in the non-excitable cells is mostly
to mediate the ion homeostasis of the cells (Yu et al., 2016).
TRPV1 acts as molecular acid sensor in the oesophagus which
activated by acidosis (pH level under 6) (Holzer, 2008). TRPV1
is overexpressed in the oesophageal mucosa of patients with
non-erosive reflux disease (NERD) and erosive esophagitis and
also in animal models of NERD (Guarino et al., 2010; Silva
et al., 2018). Increased levels of TRPV1 was also observed in
stress-induced oesophageal inflammation (Wulamu et al., 2019).
The role of TRPV1 in inflammation can be explained by the
fact that activation of the channel promotes the secretion of
inflammatory mediators (platelet-activating factor (PAF), Il- 1
β, Il-6) that initiates the inflammatory cascade in the mucosa
of the oesophagus. Therefore, inhibition of TRPV1 could be
beneficial in inflammatory conditions. Recently, Zhang et al.
have shown that menthol inhibits acid-induced inflammation
by inhibiting TRPV1 expression and TRPV1-mediated Ca2+
influx in oesophageal epithelial cells (Zhang et al., 2020). TRPV4
is also a non-selective cation channel activated by mechanical,
thermal, and chemical stimuli. Acid-sensitive TRPV4 channels
are mainly expressed in the epithelial cells of the basal and
intermediate layers of the oesophagus (Shikano et al., 2011). Ueda
et al. showed the presence of TRPV4 in human oesophageal
biopsy samples and HET-1A cell line. They demonstrated that
activation of TRPV4 increases intracellular Ca2+ level and
decreases Il-8 production that plays a role in different cellular
functions, such as cell division or viability (Ueda et al., 2011). The
presence of functionally active TRPV4 has also been shown in
mouse oesophageal keratinocytes, where activation of the channel
caused ATP release which affects the sensory nerves and might
also be related to the pathophysiology of NERD (Mihara et al.,
2011; Suzuki et al., 2015).
Oesophageal Cancer
Oesophageal cancer is a malignant neoplasm, and the sixth-
leading cause of cancer-related death worldwide (Klingelhofer
et al., 2019). The two most common types of OC are
oesophageal squamous cell carcinoma (ESCC) and oesophageal
adenocarcinoma (EAC) (Enzinger and Mayer, 2003). Current
treatment of OC includes surgery, chemo- or radiotherapy or
the combination of the three. Although OC treatment and
diagnosis have advanced, the 5-year survival rate is between
15 and 20% and recurrence is frequent (Shapiro et al., 2015).
Therefore, there is an urgent need to develop new therapies
that can complement existing treatments or allow individual
therapies. Disturbances of ion transport processes are considered
to be of great importance in cancer research (Pedersen and
Stock, 2013; Djamgoz et al., 2014; Oosterwijk and Gillies, 2014;
Stock and Schwab, 2015; Martial, 2016). Ion transporters are
not only involved in tumorigenesis by altering the membrane
permeability of certain ions, but some transporters interact with
other signaling molecules (kinases, transcription factors) that
influence the cell cycle or the metastatic potential of the cells.
In recent years, several transporters and ion channels have been
identified whose expression is altered in OC. In the following,
those ion transporters are discussed, that might provide a target
point for novel treatment or serve as prognostic markers for
ESCC or EAC (Supplementary Table S1).
Frontiers in Physiology | www.frontiersin.org 7 July 2020 | Volume 11 | Article 855
fphys-11-00855 July 16, 2020 Time: 11:16 # 8
Becskeházi et al. Ion Transport in the Osophagus
K+ Channels
Ding et al. (2008a,b) identified two voltage-gated K+ channels,
Eag1 (KV10.1, KCNH1) and hERG1 (KV11.1, KCNH2), which
are aberrantly expressed in ESCC and are correlated with poor
prognosis (Ding et al., 2008a,b). Human ether a-go-go-related
gene 1 (hERG1) over-expression has been found in BO and even
more in dysplasia and adenocarcinoma, indicating that hERG1
expression increases during BO progression to EAC (Lastraioli
et al., 2006). To support this observation, Lastraioli et al. (2016)
conducted a comprehensive study on hERG1 expression in
both mice and humans. The authors found increased hERG1
expression in two different BO mice models. They also found
that surgically induced BO more frequently develops in mice
with hERG1 over-expression. The significance of hERG1 in BO
progression to EAC has also been demonstrated in human biopsy
samples obtained from BO patients. Using monoclonal antibody
against hERG1, the 10-year follow-up showed that BO patients
with increased hERG1 expression have a higher risk of EAC
development, indicating that hERG1 can be used as a biomarker
to predict disease progression (Lastraioli et al., 2016).
Inhibitors and Therapeutic Perspectives
Potassium channel blockers are most commonly used as
antiarrhythmic agents, however, research in recent years has
shown that there is a growing need for K+ channel inhibitors
in cancer therapy as well. Currently, AZD9291 is used in
the treatment of non-small cell lung cancer (Janne et al.,
2015). AZD9291 is an epidermal growth factor receptor (EGFR)
tyrosine kinase inhibitor (TKI) that is able to inhibit hERG
channels. Another EGFR TKI, gefitinib has also been proved
to be effective in non-small cell lung cancer patients and has
shown to be beneficial in breast cancer as well (Garcia-Quiroz
et al., 2019). Experimental data demonstrated that gefitinib
dose-dependently inhibited the proliferation of cancer cells and
combined administration of this drug with the antihistamine,
astemizole resulted in a synergistic effect (Garcia-Quiroz et al.,
2019). Although the two EGFR TKIs inhibit different channels,
AZD9291 is specific for hERG channel, while gefitinib for Eag1,
they have similar mechanisms of action, both of them prevent the
channel phosphorylation which is required for the activation of
the channels (Zhang et al., 2008; Wu et al., 2012).
ANO1
Shang et al. (2016) reported a correlation between anoctamin-
1 (ANO1) expression and primary oesophageal tumor in two
independent cohorts. The authors detected strong ANO1 staining
in the tumor region of surgical specimens obtained from
ESCC patients, while the adjacent normal tissue and endoscopic
biopsies from normal mucosa and chronic oesophagitis were
completely negative for this Cl− channel (Shang et al., 2016).
In addition, ANO1 expression is correlated with the malignant
progression of precancerous oesophageal lesions, indicating that
ANO1 can be used as a biomarker to predict disease progression.
Shi et al. (2009) identified genes whose expression is altered in
ESCC and dysplasia. They found increased ANO1 levels at both
mRNA and protein levels in ESCC and dysplastic samples. In
addition, they found a correlation between ANO1 expression
and tumor progression (Shi et al., 2004). Interestingly, in the
mRNA expression of ANO1, the authors found no significant
difference between normal mucosa and oesophagitis (Shi et al.,
2009) although Vanoni et al. (2020) have shown increased
ANO1 expression in EoE. Genetic inhibition of ANO1 decreases
proliferation in ESCC cell lines, confirming the role of ANO1
in cell division. The mechanism underlying ANO1-induced
promotion of cell proliferation is unclear, although, in head
and neck squamous cell carcinoma, activation of the mitogen-
activated protein kinase (MAPK)/extracellular signal-regulated
kinase (ERK) signaling pathway is involved in the proliferative
effect of ANO1 (Duvvuri et al., 2012).
Inhibitors and Therapeutic Perspectives
Several inhibitors are known that can inhibit ANO1 with greater
or lesser potency or selectivity, such as the small molecule
inhibitor, Ani9 (Seo et al., 2016) the benzofuran derivative,
benzbromarone (Huang et al., 2012), the flavonoid, luteolin (Seo
et al., 2017) the aminophenylthiazole, [T16A(inh)-A01] or the
arylaminothiophene, CaCC(inh)-A01 (Namkung et al., 2011).
Among them, luteolin has been shown as potential anticancer
therapeutic agents for the treatment of prostate cancer (Seo et al.,
2017). This inhibitor not only blocks ANO1 activity but also
decreases its protein expression. Using PC-3, prostate cancer
cell line, administration of luteolin reduced the proliferation
and migration of the cells (Seo et al., 2017). Similar results
were observed with Ani9, T16A(inh)-A01 and CaCC(inh)-
A01 inhibitors, which also reduced PC-3 cell proliferation and
induced apoptosis, by a TNF-α-mediated signaling pathway
(Song et al., 2018). ANO1 inhibitors have also been shown to be
beneficial in ovarian cancer, where administration of LY294002
reduced the growth of cancer cells by inhibiting the PI3K/Akt
signaling pathway (Liu et al., 2019). The mechanism of action
of ANO1 inhibitors is not yet known, and there is no evidence
to date that it has been used in the treatment of inflammatory
or cancerous diseases of the oesophagus, but it could be a
promising target.
AEs
Shiozaki et al. (2017) characterized the role of AE1 and AE2
in ESCC tumorigenesis. Analysis of ESCC samples showed that
the AE1 staining intensity depends on the tumor length, while
the focal or diffuse distribution of AE1 is correlated with the
histological type and pT stage (Shiozaki et al., 2017). With regard
to 5-year survival, the staining score was not correlated with
prognosis, although diffuse AE1 expression was associated with
poor survival in advanced stages (Shiozaki et al., 2017). AE1
expression has been found in ESCC cell lines (TE5, TE8, TE9,
and KYSE150), where it is involved in cell cycle regulation
and the proliferation, apoptosis, migration and invasion of
ESCC cells via the MAPK and Hedgehog signaling pathways
(Shiozaki et al., 2017). In contrast to AE1, decreased AE2
expression is associated with poor prognosis in ESCC patients
(Shiozaki et al., 2018). There is a correlation between the AE2
staining score and the pT stage. With regard to survival, low
AE2 expression predicts a worse prognosis. Interestingly, these
correlations were observed only in the invasive front of ESCC,
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not in the entire tumor. In contrast to AE1, AE2 expression
was found in KYSE170, and TE13 ESCC cell lines and AE2
knock-down decreased apoptosis and increased migration and
invasion of ESCC cells, indicating that AE2 regulates cell survival
and cellular movements. Studies have also demonstrated that
the effect of AE2 is mediated by matrix metalloproteinases
(MMPs) and their inhibitors. Altered AE2 expression is believed
to affect tumorigenesis by altering intracellular pH. Decreased
AE2 expression favors intracellular alkalisation, which promotes
cancer cell metabolism (Persi et al., 2018).
Inhibitors and Therapeutic Perspectives
The most commonly used inhibitors of anion transporters are
the stilbene derivatives, DIDS, its reduced form dihydroDIDS
(H2DIDS) and 4-acetamido-4′-isothiocyanatostilbene-2,2′-
disulfonic acid (SITS). The negatively charged sulfonate group
of these inhibitors interact electrostatically with the anion
binding site of the transporter, resulting in a rapid, reversible
inhibition, followed by a slower covalent interaction between
the isothiocyanate group of the inhibitor and the free amino
acids of the AE. These inhibitors have low specificity and inhibit
individual isoforms with different potency (Humphreys et al.,
1994; Alper et al., 1998). There are also differences in the
efficacy of inhibitors between species and cell types. The oxonol
dye, diBA(5)C4 has been shown to inhibit the AE1 isoform
more effectively than AE2, while polyaminosterols have higher
selectivity to AE2 (Alper et al., 1998). Among the more recently
discovered AE inhibitors, 4,8-dimethyl-7-(m-bromobenzyloxy)-
coumarin-3-acetic acid has been shown to be able to completely
and selectively inhibit the SLC26A3 exchanger, and the use
of this agent showed a beneficial effect on constipation in a
mouse model (Lee et al., 2019) although, to our knowledge,
there is currently no AE inhibitor which enters or underwent in
clinical trials.
KCC3 and NKCC1
Among KCC isoforms, KCC3 expression is associated with OC
tumorigenesis (Shiozaki et al., 2014b). The presence of KCC3
in the invasive front of ESCC is associated with a low survival
rate post-operatively. The mechanism underlying KCC3’s effect
on tumor progression is unclear, but studies using ESCC cell
lines have shown that KCC3 is essential for the invasiveness of
cancer cells (Shiozaki et al., 2014b). NKCC1 is also a biomarker in
ESCC. NKCC1 expression is closely related to the differentiation
of ESCC cells, and genetic or pharmacologic inhibition of
NKCC1 in ESCC cell lines significantly decreases the rate of cell
proliferation, indicating that NKCC1 is involved in cell cycle
regulation (Shiozaki et al., 2014a).
Inhibitors and Therapeutic Perspectives
The loop diuretics, bumetanide and furosemide, are the most
commonly used inhibitors of NKCCs. Both inhibitors are able to
inhibit the co-transporter even at very low concentrations (0.5–
5 µM). Diuretics have long been used to treat fluid retention,
and in recent years their use has also emerged in the treatment
of certain neurological disorders. Therefore, several clinical
studies have been conducted to test the effect of bumetanide in
schizophrenia, epilepsy or Parkinson’s disease (Ben-Ari, 2017).
Although, the clinical use of this inhibitor is limited due to
its ionized state at physiological pH and its high binding
to plasma proteins. Recent studies suggest that azosemide is
more potent than bumetanide and has better pharmacokinetic
properties (Hampel et al., 2018). Bumetanide and furosemide at
higher concentrations (100 µM–1 mM) inhibit KCCs as well.
In addition, KCC also sensitive to DIDS, H2DIDS, and SITS,
although the inhibitory effect of these stilbene derivatives highly
depends on external K+ (Delpire and Lauf, 1992). Currently,
the most commonly used KCC inhibitor is dihydroindenyloxy
alkanoic acid (DIOA), which selectively inhibits the transporter.
The large-scale high-throughput screen on HEK293 cells
identified more potent inhibitors, such as ML077 or VU0463271,
(Delpire and Weaver, 2016) although none of these compounds
is currently under clinical development.
NHE
Among ion transporters, the expression of NHEs, especially
NHE1, alters in a metaplasia-dysplasia-adenocarcinoma
sequence. Recent studies have demonstrated that NHE1 also
plays a significant role in BO progression to EAC. Fitzgerald
et al. (1998) showed that NHE1 is involved in acid-induced cell
proliferation in BO biopsy samples in a PKC-dependent manner
(Fitzgerald et al., 1998). The cell proliferation-inducing effect
of NHE1 is explained by increased NHE1 activity at acidic pH,
which likely affects cell division by altering intracellular pH. In
contrast, bile acids alone or in combination with acid decrease
NHE1 activity in nitric oxide– and nitric oxide synthase–
dependent manner in BO-derived CP-A cells, leading to cellular
acidosis (Goldman et al., 2010). The decrease in intracellular pH
favors DNA damage, which increases the incidence of mutations
and, therefore, the risk of EAC progression (Goldman et al.,
2010). However, this workgroup also showed that bile acid
damages lysosomes as well in JH-EsoAd1 and CP-A cells and the
acidic content released from them increases NHE activity, which
forms an ionic environment that favors to apoptotic processes.
Based on these findings, it is hypothesized that by the inhibition
of NHE, the cells avoid apoptosis, increasing the risk of cancer
transformation (Goldman et al., 2011). The role of NHE1 in
OC is contradictory. Guan et al. (2014) have shown that NHE1
is over-expressed in EAC and inhibition of NHE1 expression
or blocking of NHE activity by amiloride decreases cancer cell
proliferation and induces apoptosis in both EAC and ESCC
cell lines and in nude mice xenografts. Moreover, amiloride
in combination with guggulsterone (antagonist of frasenoid
X receptor) proved to be even more effective than amiloride
alone. These results indicate that contrast to metaplastic cells,
inhibition of NHE does not enhance tumor progression but,
on the contrary, inhibits it, suggesting that NHE behaves
differently in cancerous and metaplastic cells. In contrast,
Ariyoshi et al. (2017) found that NHE1 inhibition favors the
proliferation, migration and invasion of ESCC cells because of
the up-regulation of epithelial-mesenchymal transformation
(EMT) markers and the inhibition of Notch signaling. The 5-year
overall survival (OS) was significantly higher in ESCC patients
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with high NHE1 expression, indicating the possibility of using
NHE1 as a prognostic marker (Ariyoshi et al., 2017).
Inhibitors and Therapeutic Perspectives
The most commonly used NHE1 inhibitors are amiloride
and its derivatives such as EIPA (5-(N-ethyl-N-isopropyl)
amiloride), DMA (5-(N,N-dimethyl) amiloride) and HMA
(5-(N,N-hexamethylene) amiloride) that belongs to the
pyrazinoylguanidine-type inhibitors, as well as the more specific
cariporide and epripride that belongs to the benzoylguanidine-
type inhibitors (Rolver et al., 2020). In the case of both types of
inhibitors, guanidine binds to the sodium binding site of the
exchanger, thereby competes with the sodium for the binding
site (Frelin et al., 1986). Numerous studies have suggested the
use of NHE inhibitors in the treatment of various types of cancer,
such as breast or colon cancer (Miraglia et al., 2005; Rolver
et al., 2020), however, clinical evaluation of NHE inhibitors is
currently limited to cardiac disease, particularly in connection
with ischemia-reperfusion injury, in which the cardioprotective
effect of cariporide and eniporide was demonstrated in two
clinical trials (Chaitman, 2003; Mentzer et al., 2008).
Ca2+ Channels
Orai-1 is the pore-forming subunit of the calcium-release
activated channel. By interacting with the Ca2+ sensor stromal
interaction molecule 1 (STIM-1), Orai-1 mediates store-operated
Ca2+ entry (SOCE). Orai-1 is involved in tumorigenesis in many
cancer types, including OC (Vashisht et al., 2015). Zhu et al.
(2014) reported increased Orai-1 expression in tumor tissues
obtained from ESCC patients. The Orai-1 expression is correlated
with clinicopathological features, such as histological grade,
T-stage classification and lymph node metastasis, and poor OS
and recurrence-free survival rates. Increased Orai-1 expression
and intense oscillatory Ca2+ activities are also found in ESCC
cell lines, which probably plays a role in carcinogenesis. The role
of Orai-1 in tumorigenesis has been confirmed using cell-based
assays in which Orai-1 knock-down decreased the proliferation,
migration and invasion of ESCC cells and tumor growth in nude
mice xenografts (Zhu et al., 2014). The proliferative effect of
Orai-1 might be inhibited by zinc, which selectively interacts
with the histidine residue of Orai-1 and inhibits SOCE and Ca2+
oscillations in ESCC cells (Choi et al., 2018). RP4010, a specific
Orai-1 inhibitor, also inhibits tumor growth via an unknown
mechanism and is a potential therapeutic or adjuvant drug for
ESCC treatment (Cui et al., 2018). The role of voltage-gated Ca2+
channels has also been raised in relation to OC. Voltage-gated
calcium channels are comprised of heteromultimeric complexes
that involve α1 protein in combination with various auxiliary
subunits, β, α2δ, and γ protein (Walker and De Waard, 1998).
Four α2δ subunit genes have been identified (CACNA2D1-
4) (Qin et al., 2002). The α2δ-3 subunit (CACNA2D3) is
responsible for Ca2+ influx, and its tumor suppressor function
was also characterized. It has been shown, that CACNA2D3
induces apoptosis, reduces cell motility, and provokes cell
cycle arrest in G1 phase through transactivating p53/p21
signaling pathways (Lipskaia and Lompre, 2004;Li et al., 2013).
The potential tumor suppressor role of CACNA2D3 in the
pathomechanism of malignancies has been mentioned in several
studies. Considering the GI tract, the promoter methylation of
this gene is in association with poor prognosis of gastric cancer
(Wanajo et al., 2008). Li et al. showed that downregulation of
CACNA2D3 could be detected in ESCC patients that showed
a positive correlation with a poor progression and low overall
survival rate (Li et al., 2013). A recent study indicates, that
overexpression of CACNA2D3 can restore chemosensitivity of
ESCC cells to cisplatin via inhibition of PI3K/Akt pathway,
which is a promising finding regarding the therapy of ESCC
(Nie et al., 2019).
TRPC6 proteins are non-selective cation channels, which
are permeable to cations (Ca2+, Na +, K+, Cs+ and Ba2+)
iron, zinc and N-methyl-D-glucamine (Bouron et al., 2016).
TRPC6 seems to be ubiquitous in the human body and
involved in the regulation of intracellular Ca2+ concentration
(Hofmann et al., 2000). There are several activators of the TRPC6
channels, such as extracellular Ca2+ concentration,(Shi et al.,
2004) diacylglycerol (DAG) and its analogs, such as 1-oleoyl-
2-acetyl-sn-glycerol, and arachidonic acids (Aires et al., 2007)
and hyperforin (Leuner et al., 2007). Literature data indicate
that TRPC6 is associated with tumorigenesis, tumor growth and
elevated TRPC6 expression was detected in many cancer types
(Santoni and Farfariello, 2011). It has been reported that TRPC6
expression significantly higher in ESCC patients, and it correlates
with poor progression (Shi et al., 2009; Zhang et al., 2013). Shi
et al. have shown, that inhibition of TRPC6 resulted in cell cycle
arrest at G2 phase, reduced cell growth in ESCC cells and the
formation of tumor in nude mice (Shi et al., 2009). Evaluating
this finding (Ding et al., 2010) have raised the possibility that
inhibition of TRPC6 can increase the radiosensitivity of tumor
cells and also inhibits angiogenesis in the therapy of ESCC.
Similar results have been found by Zhang et al. Using an ESCC
cell line, Eca109 they showed that administration of the TRPC
inhibitor, SKF96365 arrested the cell cycle at G2/M phase, and
in combination with radiation it significantly reduced in vitro cell
proliferation and the tumor size in nude mice (Zhang et al., 2017).
The role of TRPVs has arisen primarily in the inflammatory
diseases of the oesophagus (GERD, NERD); although Huang
et al. have also shown its importance in ESCC (Huang et al.,
2019). They found that both TRPV1 and -4 are up-regulated in
ESCC, and overactivation of these channels can modulate the
proliferation and migration of ESCC cells, by the regulation of
intracellular Ca2+ concentration (Huang et al., 2019).
Inhibitors and Therapeutic Perspectives
Ca2+ channels are aberrantly regulated in most of the cancer
cells; therefore, great efforts are made to develop novel drugs
that are able to modulate the function of these channels.
Inhibition of Ca2+ channels is a promising target in cancer
therapy, and there are Ca2+ channel blockers that have already
undergone clinical trials or are under clinical development.
The specific Orai-1 inhibitor, RP4010 completed a Phase I/Ib
clinical trial in which the safety and efficacy of RP4010
were evaluated in lymphoma. In addition, RP4010 significantly
reduced cell division, especially in combination with anticancer
agents in pancreatic ductal adenocarcinoma (Khan et al., 2020).
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The recently identified SOR-C13 is an inhibitor of TRPV6
channels that selectively binds to the channel and prevents
the influx of Ca2+ into the cells. SOR-C13 has been shown
to be effective in ovarian cancer (Xue et al., 2018) and is
currently undergoing Phase I clinical trials to determine the
best dose and side effect profile of this drug, in advanced
refractory solid tumors.
Aquaporins
Ion movement is accompanied by water movement. Transcellular
water transport is mediated by aquaporins (AQPs). The main
driving force of AQPs is the osmotic difference between the intra-
and the extracellular space. In addition to water transport, AQPs
are involved in the transport of smaller molecules or function as
ion channels. Several mechanisms have been described through
which AQPs enhance tumor cell migration and invasion (De Ieso
and Yool, 2018). AQP1 facilitates hypoxia-induced angiogenesis,
AQP1, -3, -4, -5, and -9 are involved in epithelial-mesenchymal
transition and extracellular matrix degradation, whereas AQP1-
4 enhance cell adhesion (De Ieso and Yool, 2018). Of the
13 isoforms currently identified, AQP1, -3, -5, and -8 are
associated with OC. AQP1 is widely expressed in many tissues
and is a potential biomarker in breast cancer (Qin et al.,
2016). Yamazato et al. (2018) found a correlation between
AQP1 expression and the outcome of ESCC patients (Yamazato
et al., 2018). The authors showed that in ESCC patients with
high AQP1 expression in the cytoplasm, the 5-year survival
rate is lower compared to ESCC patients in whom AQP1 is
localized to the nuclear membrane. AQP1 knock-down in ESCC
cell lines inhibits cell proliferation and migration and induces
apoptosis. In addition, microarray analysis shows an interaction
between AQP1 and death-receptor signaling pathway-related
genes, supporting the importance of AQP1 in tumorigenesis.
Similar results were observed for AQP3 (Kusayama et al., 2011;
Niu et al., 2012). AQP3 is highly expressed in ESCC, and
the absence or decreased function of AQP3 decreases adhesion
of cancerous cells via inhibition of integrins and the focal
adhesion kinase–mitogen-activated protein kinase (FAK-MAPK)
signaling pathway. Inhibition of cell adhesion is associated with
decreased cell growth and apoptosis, indicating the critical role
of AQP3 in cell survival. Increased expression of AQP3 in
ESCC and EAC has also been demonstrated by Niu et al.
(2012). Studies have also reported the importance of AQP5 in
ESCC (Shimizu et al., 2014). AQP5 down-regulation inhibits
cell cycle progression in ESCC cell lines, and microarray
analysis shows that a lack of AQP5 affects the expression
of genes involved in cellular growth. Studies have shown a
correlation between the size and histological type of ESCC
and AQP5 expression in human tumor tissues. In addition,
the 3-year progression-free survival is lower in ESCC patients
with AQP5 positivity, which raises the possibility of using
AQP5 as a biomarker. AQP8 has also been implicated in the
progression of OC (Chang et al., 2014). Using human ESCC
cell line, Eca-109, it has been shown that the epidermal growth
factor (EGF)-induced cell migration is associated with increased
expression of AQP8 through the EGF receptor-ERK1/2 signal
transduction pathway.
Inhibitors and Therapeutic Perspectives
Several inhibitors have been identified that are more or less
effective in inhibiting AQPs, such as the small molecule
inhibitors, TEA and acetazolamide, which can selectively and
reversibly inhibit AQP1 and -4 isoforms (Abir-Awan et al., 2019).
The recently discovered molecules, DFP00173 and Z433927330
that have been shown to block glyceroporins by reducing channel
glycerol permeability (Abir-Awan et al., 2019). Among the heavy
metal ions, Cu ions, NiCl2 and gold compounds proved to be
effective in inhibiting AQP3 (Aikman et al., 2018). HgCl2 is
also widely used to inhibit AQPs, however, the disadvantage of
this molecule is that it blocks all AQP isoforms and mercury
is highly toxic to cells due to its many side effects (Aikman
et al., 2018). Furthermore, monoclonal antibodies such as anti-
AQP4 have been shown to be promising agents in the treatment
of neuromyelitis optica (NMO) (Tradtrantip et al., 2012) and
clinical trials are in progress to evaluate the efficacy of anti-
AQP4 IgG in NMO and multiple sclerosis. To the best of our
knowledge, no controlled clinical trial has been conducted to
date in which the effects of AQP inhibitors have been tested in
oesophageal diseases.
CONCLUSION
This review summarized the expression and role of ion
transporters in OECs (Tables 1, 2) and described their
pathological function (Supplementary Table S1). Ion transport
fundamentally determines both the extra- and the intracellular
pH, which affects several intracellular mechanisms, including
the release of inflammatory mediators or the expression of
cell cycle regulatory proteins. Research increasingly highlights
the significance of ion transporters in various inflammatory
and cancerous processes, and many of them have emerged as
promising therapeutic targets or independent prognostic factors
in cancer. This review described numerous ion transporters
whose inhibition reduces proliferation and induces apoptosis
of cancerous oesophageal cells (Supplementary Table S1).
These findings raise the possibility that pharmacological
inhibition of these ion transporters or a combination of
ion transporter inhibitors with chemotherapeutic agents might
provide alternative treatment options for OC patients who do not
respond to standard treatment.
AUTHOR CONTRIBUTIONS
VV, EB, and MK contributed to conception and design of the
study. EB and PH wrote separate sections of the manuscript. All
authors read and approved the submitted version.
FUNDING
This study was supported by the National Research,
Development and Innovation Office (FK123982), the
Frontiers in Physiology | www.frontiersin.org 11 July 2020 | Volume 11 | Article 855
fphys-11-00855 July 16, 2020 Time: 11:16 # 12
Becskeházi et al. Ion Transport in the Osophagus
Economic Development and Innovation Operational
Programme Grant (GINOP-2.3.2-15-2016-00015), and the
National Research, Development and Innovation Office,
by the Ministry of Human Capacities (EFOP 3.6.2-16-
2017-00006).
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found
online at: https://www.frontiersin.org/articles/10.3389/fphys.
2020.00855/full#supplementary-material
REFERENCES
Abdulnour-Nakhoul, S., Bor, S., Imeryuz, N., and Orlando, R. C. (1999).
Mechanisms of basolateral Na+ transport in rabbit esophageal epithelial cells.
Am. J. Physiol. 276, G507–G517.
Abdulnour-Nakhoul, S., Nakhoul, H. N., Kalliny, M. I., Gyftopoulos, A., Rabon,
E., Doetjes, R., et al. (2011). Ion transport mechanisms linked to bicarbonate
secretion in the esophageal submucosal glands. Am. J. Physiol. Regul. Integr.
Comp. Physiol. 301, R83–R96.
Abdulnour-Nakhoul, S., Nakhoul, N. L., Caymaz-Bor, C., and Orlando, R. C.
(2002). Chloride transport in rabbit esophageal epithelial cells. Am. J. Physiol.
Gastrointest. Liver Physiol. 282, G663–G675.
Abdulnour-Nakhoul, S., Nakhoul, N. L., Wheeler, S. A., Wang, P., Swenson, E. R.,
and Orlando, R. C. (2005). HCO3- secretion in the esophageal submucosal
glands. Am. J. Physiol. Gastrointest. Liver Physiol. 288, G736–G744.
Abir-Awan, M., Kitchen, P., Salman, M. M., Conner, M. T., Conner, A. C., and Bill,
R. M. (2019). Inhibitors of mammalian aquaporin water channels. Int. J. Mol.
Sci. 20:1589. doi: 10.3390/ijms20071589
Aikman, B., De Almeida, A., Meier-Menches, S. M., and Casini, A. (2018).
Aquaporins in cancer development: opportunities for bioinorganic chemistry
to contribute novel chemical probes and therapeutic agents. Metallomics 10,
696–712. doi: 10.1039/c8mt00072g
Aires, V., Hichami, A., Boulay, G., and Khan, N. A. (2007). Activation of TRPC6
calcium channels by diacylglycerol (DAG)-containing arachidonic acid: a
comparative study with DAG-containing docosahexaenoic acid. Biochimie 89,
926–937. doi: 10.1016/j.biochi.2006.10.016
Akar, F., Jiang, G., Paul, R. J., and O’neill, W. C. (2001). Contractile regulation of the
Na(+)-K(+)-2Cl(-) cotransporter in vascular smooth muscle. Am. J. Physiol.
Cell Physiol. 281, C579–C584.
Alper, S. L., Chernova, M. N., Williams, J., Zasloff, M., Law, F. Y., and Knauf, P. A.
(1998). Differential inhibition of AE1 and AE2 anion exchangers by oxonol
dyes and by novel polyaminosterol analogs of the shark antibiotic squalamine.
Biochem. Cell Biol. 76, 799–806. doi: 10.1139/o98-082
Ariyoshi, Y., Shiozaki, A., Ichikawa, D., Shimizu, H., Kosuga, T., Konishi, H., et al.
(2017). Na+/H+ exchanger 1 has tumor suppressive activity and prognostic
value in esophageal squamous cell carcinoma. Oncotarget 8, 2209–2223. doi:
10.18632/oncotarget.13645
Awayda, M. S., Bengrine, A., Tobey, N. A., Stockand, J. D., and Orlando, R. C.
(2004). Nonselective cation transport in native esophageal epithelia. Am. J.
Physiol. Cell Physiol. 287, C395–C402.
Ben-Ari, Y. (2017). NKCC1 chloride importer antagonists attenuate many
neurological and psychiatric disorders. Trends Neurosci. 40, 536–554. doi:
10.1016/j.tins.2017.07.001
Ben-Ari, Y., Gaiarsa, J. L., Tyzio, R., and Khazipov, R. (2007). GABA: a pioneer
transmitter that excites immature neurons and generates primitive oscillations.
Physiol. Rev. 87, 1215–1284. doi: 10.1152/physrev.00017.2006
Blanchard, C., Stucke, E. M., Burwinkel, K., Caldwell, J. M., Collins, M. H.,
Ahrens, A., et al. (2010). Coordinate interaction between IL-13 and epithelial
differentiation cluster genes in eosinophilic esophagitis. J. Immunol. 184, 4033–
4041. doi: 10.4049/jimmunol.0903069
Bonar, P. T., and Casey, J. R. (2008). Plasma membrane Cl(-)/HCO(3)(-)
exchangers: structure, mechanism and physiology. Channels 2, 337–345. doi:
10.4161/chan.2.5.6899
Bouron, A., Chauvet, S., Dryer, S., and Rosado, J. A. (2016). Second messenger-
operated calcium entry through TRPC6. Adv. Exp. Med. Biol. 898, 201–249.
doi: 10.1007/978-3-319-26974-0_10
Castrop, H., and Schiessl, I. M. (2014). Physiology and pathophysiology of the
renal Na-K-2Cl cotransporter (NKCC2). Am. J. Physiol. Renal Physiol. 307,
F991–F1002.
Chaitman, B. R. (2003). A review of the GUARDIAN trial results: clinical
implications and the significance of elevated perioperative CK-MB on 6-month
survival. J. Card. Surg. 18(Suppl. 1), 13–20. doi: 10.1046/j.1540-8191.18.s1.3.x
Chang, H., Shi, Y. H., Talaf, T. K., and Lin, C. (2014). Aquaporin-8 mediates human
esophageal cancer Eca-109 cell migration via the EGFR-Erk1/2 pathway. Int. J.
Clin. Exp. Pathol. 7, 7663–7671.
Choi, S., Cui, C., Luo, Y., Kim, S. H., Ko, J. K., Huo, X., et al. (2018). Selective
inhibitory effects of zinc on cell proliferation in esophageal squamous cell
carcinoma through Orai1. FASEB J. 32, 404–416. doi: 10.1096/fj.201700227rrr
Collins, M. H. (2008). Histopathologic features of eosinophilic esophagitis.
Gastrointest. Endosc. Clin. N. Am. 18, 59–71. doi: 10.1016/j.giec.2007.
09.014
Cotton, C. U. (2000). Basolateral potassium channels and epithelial ion transport.
Am. J. Respir. Cell Mol. Biol. 23, 270–272. doi: 10.1165/ajrcmb.23.3.f198
Cui, C., Chang, Y., Zhang, X., Choi, S., Tran, H., Penmetsa, K. V., et al. (2018).
Targeting Orai1-mediated store-operated calcium entry by RP4010 for anti-
tumor activity in esophagus squamous cell carcinoma. Cancer Lett. 432, 169–
179. doi: 10.1016/j.canlet.2018.06.006
Czepan, M., Rakonczay, Z., Varro, A., Steele, I., Dimaline, R., Lertkowit, N.,
et al. (2012). NHE1 activity contributes to migration and is necessary for
proliferation of human gastric myofibroblasts. Pflugers Arch. 463, 459–475.
doi: 10.1007/s00424-011-1059-6
De Ieso, M. L., and Yool, A. J. (2018). Mechanisms of aquaporin-facilitated cancer
invasion and metastasis. Front. Chem. 6:135. doi: 10.3389/fchem.2018.00135
Delpire, E., and Lauf, P. K. (1992). Kinetics of DIDS inhibition of swelling-activated
K-Cl cotransport in low K sheep erythrocytes. J. Membr. Biol. 126, 89–96.
Delpire, E., and Weaver, C. D. (2016). Challenges of finding novel drugs targeting
the K-Cl cotransporter. ACS Chem. Neurosci. 7, 1624–1627. doi: 10.1021/
acschemneuro.6b00366
Demaurex, N., and Grinstein, S. (1994). Na+/H+ antiport: modulation by ATP
and role in cell volume regulation. J. Exp. Biol. 196, 389–404.
Denker, S. P., Huang, D. C., Orlowski, J., Furthmayr, H., and Barber, D. L. (2000).
Direct binding of the Na–H exchanger NHE1 to ERM proteins regulates the
cortical cytoskeleton and cell shape independently of H(+) translocation. Mol.
Cell 6, 1425–1436. doi: 10.1016/s1097-2765(00)00139-8
Ding, X., He, Z., Shi, Y., Wang, Q., and Wang, Y. (2010). Targeting TRPC6 channels
in oesophageal carcinoma growth. Expert Opin. Ther. Targets 14, 513–527.
doi: 10.1517/14728221003733602
Ding, X. W., Luo, H. S., Luo, B., Xu, D. Q., and Gao, S. (2008a). Overexpression
of hERG1 in resected esophageal squamous cell carcinomas: a marker for poor
prognosis. J. Surg. Oncol. 97, 57–62. doi: 10.1002/jso.20891
Ding, X. W., Wang, X. G., Luo, H. S., Tan, S. Y., Gao, S., Luo, B., et al. (2008b).
Expression and prognostic roles of Eag1 in resected esophageal squamous cell
carcinomas. Dig. Dis. Sci. 53, 2039–2044. doi: 10.1007/s10620-007-0116-7
Djamgoz, M. B., Coombes, R. C., and Schwab, A. (2014). Ion transport and
cancer: from initiation to metastasis. Philos. Trans. R. Soc. Lond. B Biol. Sci.
369:20130092. doi: 10.1098/rstb.2013.0092
Donowitz, M., Ming Tse, C., and Fuster, D. (2013). SLC9/NHE gene family, a
plasma membrane and organellar family of Na(+)/H(+) exchangers. Mol.
Aspects Med. 34, 236–251. doi: 10.1016/j.mam.2012.05.001
Duvvuri, U., Shiwarski, D. J., Xiao, D., Bertrand, C., Huang, X., Edinger, R. S., et al.
(2012). TMEM16A induces MAPK and contributes directly to tumorigenesis
and cancer progression. Cancer Res. 72, 3270–3281. doi: 10.1158/0008-5472.
can-12-0475-t
Enzinger, P. C., and Mayer, R. J. (2003). Esophageal cancer. N. Engl. J. Med. 349,
2241–2252.
Farkas, K., Yeruva, S., Rakonczay, Z., Ludolph, L., Molnar, T., Nagy, F., et al. (2011).
New therapeutic targets in ulcerative colitis: the importance of ion transporters
in the human colon. Inflamm. Bowel Dis. 17, 884–898. doi: 10.1002/ibd.21432
Frontiers in Physiology | www.frontiersin.org 12 July 2020 | Volume 11 | Article 855
fphys-11-00855 July 16, 2020 Time: 11:16 # 13
Becskeházi et al. Ion Transport in the Osophagus
Fitzgerald, R. C., Omary, M. B., and Triadafilopoulos, G. (1998). Altered sodium-
hydrogen exchange activity is a mechanism for acid-induced hyperproliferation
in Barrett’s esophagus. Am. J. Physiol. 275, G47–G55.
Frelin, C., Vigne, P., Barbry, P., and Lazdunski, M. (1986). Interaction of
guanidinium and guanidinium derivatives with the Na+/H+ exchange system.
Eur. J. Biochem. 154, 241–245. doi: 10.1111/j.1432-1033.1986.tb09388.x
Frizzell, R. A., and Hanrahan, J. W. (2012). Physiology of epithelial chloride and
fluid secretion. Cold Spring Harb. Perspect. Med. 2:a009563. doi: 10.1101/
cshperspect.a009563
Fujiwara, Y., Higuchi, K., Tominaga, K., Watanabe, T., Oshitani, N., and
Arakawa, T. (2005). Functional oesophageal epithelial defense against acid.
Inflammopharmacology 13, 1–13. doi: 10.1163/156856005774423953
Furuta, G. T., and Katzka, D. A. (2015). Eosinophilic Esophagitis. N. Engl. J. Med.
373, 1640–1648.
Garcia-Quiroz, J., Gonzalez-Gonzalez, M. E., Diaz, L., Ordaz-Rosado, D., Segovia-
Mendoza, M., Prado-Garcia, H., et al. (2019). Astemizole, an inhibitor of
Ether-a-Go-Go-1 potassium channel, increases the activity of the tyrosine
kinase inhibitor Gefitinib in breast cancer cells. Rev. Invest. Clin. 71, 186–194.
Goldman, A., Chen, H., Khan, M. R., Roesly, H., Hill, K. A., Shahidullah, M., et al.
(2011). The Na+/H+ exchanger controls deoxycholic acid-induced apoptosis
by a H+-activated, Na+-dependent ionic shift in esophageal cells. PLoS One
6:e23835. doi: 10.1371/journal.pone.0023835
Goldman, A., Shahidullah, M., Goldman, D., Khailova, L., Watts, G., Delamere, N.,
et al. (2010). A novel mechanism of acid and bile acid-induced DNA damage
involving Na+/H+ exchanger: implication for Barrett’s oesophagus. Gut 59,
1606–1616. doi: 10.1136/gut.2010.213686
Goldstein, J. L., Fogelson, B. G., Snow, J. C., Schmidt, L. N., Mozwecz, H., and
Layden, T. J. (1993). Rabbit esophageal cells possess K+ channels: effect of
hyposmotic stress on channel activity. Gastroenterology 104, 417–426. doi:
10.1016/0016-5085(93)90409-6
Goldstein, J. L., Watkins, J. L., Greager, J. A., and Layden, T. J. (1994).
The esophageal mucosal resistance: structure and function of an unique
gastrointestinal epithelial barrier. J. Lab. Clin. Med. 123, 653–659.
Grinstein, S., Rotin, D., and Mason, M. J. (1989). Na+/H+ exchange and growth
factor-induced cytosolic pH changes. Role in cellular proliferation. Biochim.
Biophys. Acta 988, 73–97. doi: 10.1016/0304-4157(89)90004-x
Guan, B., Hoque, A., and Xu, X. (2014). Amiloride and guggulsterone suppression
of esophageal cancer cell growth in vitro and in nude mouse xenografts. Front.
Biol. 9, 75–81. doi: 10.1007/s11515-014-1289-z
Guarino, M. P., Cheng, L., Ma, J., Harnett, K., Biancani, P., Altomare, A., et al.
(2010). Increased TRPV1 gene expression in esophageal mucosa of patients
with non-erosive and erosive reflux disease. Neurogastroenterol. Motil. 22,746–
51.e219.
Gunther, C., Neumann, H., and Vieth, M. (2014). Esophageal epithelial resistance.
Dig. Dis. 32, 6–10. doi: 10.1159/000357001
Haas, M., and Forbush, B. (1998). The Na-K-Cl cotransporters. J. Bioenerg.
Biomembr. 30, 161–172.
Haas, M., and Forbush, B. (2000). The Na-K-Cl cotransporter of secretory epithelia.
Annu. Rev. Physiol. 62, 515–534. doi: 10.1146/annurev.physiol.62.1.515
Hampel, P., Romermann, K., Macaulay, N., and Loscher, W. (2018). Azosemide
is more potent than bumetanide and various other loop diuretics to inhibit
the sodium-potassium-chloride-cotransporter human variants hNKCC1A and
hNKCC1B. Sci. Rep. 8:9877.
Hegyi, P., Pandol, S., Venglovecz, V., and Rakonczay, Z. Jr. (2011). The acinar-
ductal tango in the pathogenesis of acute pancreatitis. Gut 60, 544–552. doi:
10.1136/gut.2010.218461
Heitzmann, D., and Warth, R. (2008). Physiology and pathophysiology of
potassium channels in gastrointestinal epithelia. Physiol. Rev. 88, 1119–1182.
doi: 10.1152/physrev.00020.2007
Hofmann, T., Schaefer, M., Schultz, G., and Gudermann, T. (2000). Transient
receptor potential channels as molecular substrates of receptor-mediated cation
entry. J. Mol. Med. 78, 14–25. doi: 10.1007/s001090050378
Holzer, P. (2008). The pharmacological challenge to tame the transient receptor
potential vanilloid-1 (TRPV1) nocisensor. Br. J. Pharmacol. 155, 1145–1162.
doi: 10.1038/bjp.2008.351
Huang, F., Zhang, H., Wu, M., Yang, H., Kudo, M., Peters, C. J., et al. (2012).
Calcium-activated chloride channel TMEM16A modulates mucin secretion
and airway smooth muscle contraction. Proc. Natl. Acad. Sci. U.S.A. 109,
16354–16359. doi: 10.1073/pnas.1214596109
Huang, R., Wang, F., Yang, Y., Ma, W., Lin, Z., Cheng, N., et al. (2019). Recurrent
activations of transient receptor potential vanilloid-1 and vanilloid-4 promote
cellular proliferation and migration in esophageal squamous cell carcinoma
cells. FEBS Open Bio 9, 206–225. doi: 10.1002/2211-5463.12570
Humphreys, B. D., Jiang, L., Chernova, M. N., and Alper, S. L. (1994). Functional
characterization and regulation by pH of murine AE2 anion exchanger
expressed in Xenopus oocytes. Am. J. Physiol. 267, C1295–C1307.
Janne, P. A., Yang, J. C., Kim, D. W., Planchard, D., Ohe, Y., Ramalingam, S. S.,
et al. (2015). AZD9291 in EGFR inhibitor-resistant non-small-cell lung cancer.
N. Engl. J. Med. 372, 1689–1699.
Judak, L., Hegyi, P., Rakonczay, Z., Maleth, J., Gray, M. A., and Venglovecz,
V. (2014). Ethanol and its non-oxidative metabolites profoundly inhibit
CFTR function in pancreatic epithelial cells which is prevented by ATP
supplementation. Pflugers Arch. 466, 549–562. doi: 10.1007/s00424-013-1333-
x
Jung, J., Nam, J. H., Park, H. W., Oh, U., Yoon, J. H., and Lee, M. G.
(2013). Dynamic modulation of ANO1/TMEM16A HCO3(-) permeability by
Ca2+/calmodulin. Proc. Natl. Acad. Sci. U.S.A. 110, 360–365. doi: 10.1073/
pnas.1211594110
Kere, J. (2006). Overview of the SLC26 family and associated diseases. Novartis
Found. Symp. 273, 2–11.
Khalbuss, W. E., Alkiek, R., Marousis, C. G., and Orlando, R. C. (1993). Potassium
conductance in rabbit esophageal epithelium. Am. J. Physiol. 265, G28–G34.
Khan, H. Y., Mpilla, G. B., Sexton, R., Viswanadha, S., Penmetsa, K. V.,
Aboukameel, A., et al. (2020). Calcium Release-Activated Calcium
(CRAC) channel inhibition suppresses pancreatic ductal adenocarcinoma
cell proliferation and patient-derived tumor growth. Cancers 12:750.
doi: 10.3390/cancers12030750
Kleyman, T. R., and Cragoe, E. J. (1988). Amiloride and its analogs as tools in the
study of ion transport. J. Membr. Biol. 105, 1–21. doi: 10.1007/bf01871102
Klingelhofer, D., Zhu, Y., Braun, M., Bruggmann, D., Schoffel, N., and Groneberg,
D. A. (2019). A world map of esophagus cancer research: a critical accounting.
J. Transl. Med. 17:150.
Kusayama, M., Wada, K., Nagata, M., Ishimoto, S., Takahashi, H., Yoneda, M.,
et al. (2011). Critical role of aquaporin 3 on growth of human esophageal and
oral squamous cell carcinoma. Cancer Sci. 102, 1128–1136. doi: 10.1111/j.1349-
7006.2011.01927.x
Lacroix, J., Poet, M., Maehrel, C., and Counillon, L. (2004). A mechanism for
the activation of the Na/H exchanger NHE-1 by cytoplasmic acidification and
mitogens. EMBO Rep. 5, 91–96. doi: 10.1038/sj.embor.7400035
Laczko, D., Rosztoczy, A., Birkas, K., Katona, M., Rakonczay, Z., Tiszlavicz, L., et al.
(2016). Role of ion transporters in the bile acid-induced esophageal injury. Am.
J. Physiol. Gastrointest. Liver Physiol. 311, G16–G31.
Lastraioli, E., Lottini, T., Iorio, J., Freschi, G., Fazi, M., Duranti, C., et al. (2016).
hERG1 behaves as biomarker of progression to adenocarcinoma in Barrett’s
esophagus and can be exploited for a novel endoscopic surveillance. Oncotarget
7, 59535–59547. doi: 10.18632/oncotarget.11149
Lastraioli, E., Taddei, A., Messerini, L., Comin, C. E., Festini, M., Giannelli, M.,
et al. (2006). hERG1 channels in human esophagus: evidence for their aberrant
expression in the malignant progression of Barrett’s esophagus. J. Cell. Physiol.
209, 398–404. doi: 10.1002/jcp.20748
Layden, T. J., Agnone, L. M., Schmidt, L. N., Hakim, B., and Goldstein, J. L.
(1990). Rabbit esophageal cells possess an Na+,H+ antiport. Gastroenterology
99, 909–917. doi: 10.1016/0016-5085(90)90606-2
Layden, T. J., Schmidt, L., Agnone, L., Lisitza, P., Brewer, J., and Goldstein, J. L.
(1992). Rabbit esophageal cell cytoplasmic pH regulation: role of Na+-H+
antiport and H+-dependent HCO3- transport systems. Am. J. Physiol. 263,
G407–G413.
Lee, M. G., Ohana, E., Park, H. W., Yang, D., and Muallem, S. (2012). Molecular
mechanism of pancreatic and salivary gland fluid and HCO3 secretion. Physiol.
Rev. 92, 39–74. doi: 10.1152/physrev.00011.2011
Lee, S., Cil, O., Haggie, P. M., and Verkman, A. S. (2019). 4,8-Dimethylcoumarin
Inhibitors of Intestinal Anion Exchanger slc26a3 (Downregulated in Adenoma)
for Anti-Absorptive Therapy of Constipation. J. Med. Chem. 62, 8330–8337.
doi: 10.1021/acs.jmedchem.9b01192
Frontiers in Physiology | www.frontiersin.org 13 July 2020 | Volume 11 | Article 855
fphys-11-00855 July 16, 2020 Time: 11:16 # 14
Becskeházi et al. Ion Transport in the Osophagus
Leuner, K., Kazanski, V., Muller, M., Essin, K., Henke, B., Gollasch, M., et al. (2007).
Hyperforin–a key constituent of St. John’s wort specifically activates TRPC6
channels. FASEB J. 21, 4101–4111. doi: 10.1096/fj.07-8110com
Li, Y., Zhu, C. L., Nie, C. J., Li, J. C., Zeng, T. T., Zhou, J., et al. (2013). Investigation
of tumor suppressing function of CACNA2D3 in esophageal squamous cell
carcinoma. PLoS One 8:e60027. doi: 10.1371/journal.pone.0060027
Lin, B. R., Hsieh, H. T., Lee, J. M., Lai, I. R., Chen, C. F., and Yu, L. C. (2008).
Luminal hydrochloric acid stimulates rapid transepithelial ion fluxes in rodent
esophageal stratified squamous epithelium. J. Physiol. Pharmacol. 59, 525–542.
Lipskaia, L., and Lompre, A. M. (2004). Alteration in temporal kinetics of Ca2+
signaling and control of growth and proliferation. Biol. Cell 96, 55–68. doi:
10.1016/j.biolcel.2003.11.001
Liu, Z., Zhang, S., Hou, F., Zhang, C., Gao, J., and Wang, K. (2019). Inhibition of
Ca(2+) -activated chloride channel ANO1 suppresses ovarian cancer through
inactivating PI3K/Akt signaling. Int. J. Cancer 144, 2215–2226. doi: 10.1002/
ijc.31887
Martial, S. (2016). Involvement of ion channels and transporters in carcinoma
angiogenesis and metastasis. Am. J. Physiol. Cell Physiol. 310, C710–C727.
Mentzer, R. M., Bartels, C., Bolli, R., Boyce, S., Buckberg, G. D., Chaitman, B.,
et al. (2008). Sodium-hydrogen exchange inhibition by cariporide to reduce the
risk of ischemic cardiac events in patients undergoing coronary artery bypass
grafting: results of the EXPEDITION study. Ann. Thorac. Surg. 85, 1261–1270.
doi: 10.1016/j.athoracsur.2007.10.054
Mihara, H., Boudaka, A., Sugiyama, T., Moriyama, Y., and Tominaga, M. (2011).
Transient receptor potential vanilloid 4 (TRPV4)-dependent calcium influx and
ATP release in mouse oesophageal keratinocytes. J. Physiol. 589, 3471–3482.
doi: 10.1113/jphysiol.2011.207829
Miraglia, E., Viarisio, D., Riganti, C., Costamagna, C., Ghigo, D., and Bosia,
A. (2005). Na+/H+ exchanger activity is increased in doxorubicin-resistant
human colon cancer cells and its modulation modifies the sensitivity of the cells
to doxorubicin. Int. J. Cancer 115, 924–929. doi: 10.1002/ijc.20959
Namkung, W., Phuan, P. W., and Verkman, A. S. (2011). TMEM16A inhibitors
reveal TMEM16A as a minor component of calcium-activated chloride channel
conductance in airway and intestinal epithelial cells. J. Biol. Chem. 286, 2365–
2374. doi: 10.1074/jbc.m110.175109
Nie, C., Qin, X., Li, X., Tian, B., Zhao, Y., Jin, Y., et al. (2019). CACNA2D3 enhances
the chemosensitivity of esophageal squamous cell carcinoma to cisplatin via
inducing Ca(2+)-mediated apoptosis and suppressing PI3K/Akt pathways.
Front. Oncol. 9:185. doi: 10.3389/fonc.2019.00185
Nilius, B., and Owsianik, G. (2011). The transient receptor potential family of ion
channels. Genome Biol. 12:218. doi: 10.1186/gb-2011-12-3-218
Niu, D., Kondo, T., Nakazawa, T., Yamane, T., Mochizuki, K., Kawasaki, T., et al.
(2012). Expression of aquaporin3 in human neoplastic tissues. Histopathology
61, 543–551. doi: 10.1111/j.1365-2559.2011.04165.x
Oosterwijk, E., and Gillies, R. J. (2014). Targeting ion transport in cancer. Philos.
Trans. R. Soc. Lond. B Biol. Sci. 369:20130107. doi: 10.1098/rstb.2013.0107
Orlando, G. S., Tobey, N. A., Wang, P., Abdulnour-Nakhoul, S., and Orlando, R. C.
(2002). Regulatory volume decrease in human esophageal epithelial cells. Am.
J. Physiol. Gastrointest. Liver Physiol. 283, G932–G937.
Orlando, R. C. (1986). Esophageal epithelial resistance. J. Clin.
Gastroenterol. 8(Suppl. 1), 12–16. doi: 10.1097/00004836-198606001-
00004
Orlando, R. C., Bryson, J. C., and Powell, D. W. (1984). Mechanisms of H+ injury
in rabbit esophageal epithelium. Am. J. Physiol. 246, G718–G724.
Orlando, R. C., Powell, D. W., and Carney, C. N. (1981). Pathophysiology of
acute acid injury in rabbit esophageal epithelium. J. Clin. Invest. 68, 286–293.
doi: 10.1172/jci110246
Park, S. Y., Lee, Y. J., Cho, E. J., Shin, C. Y., and Sohn, U. D. (2015). Intrinsic
resistance triggered under acid loading within normal esophageal epithelial
cells: NHE1- and ROS-mediated survival. J. Cell. Physiol. 230, 1503–1514. doi:
10.1002/jcp.24896
Pedersen, S. F., and Stock, C. (2013). Ion channels and transporters in cancer:
pathophysiology, regulation, and clinical potential. Cancer Res. 73, 1658–1661.
doi: 10.1158/0008-5472.can-12-4188
Persi, E., Duran-Frigola, M., Damaghi, M., Roush, W. R., Aloy, P., Cleveland,
J. L., et al. (2018). Systems analysis of intracellular pH vulnerabilities for cancer
therapy. Nat. Commun. 9:2997.
Powell, D. W., Morris, S. M., and Boyd, D. D. (1975). Water and electrolyte
transport by rabbit esophagus. Am. J. Physiol. 229, 438–443. doi: 10.1152/
ajplegacy.1975.229.2.438
Qin, F., Zhang, H., Shao, Y., Liu, X., Yang, L., Huang, Y., et al. (2016). Expression of
aquaporin1, a water channel protein, in cytoplasm is negatively correlated with
prognosis of breast cancer patients. Oncotarget 7, 8143–8154. doi: 10.18632/
oncotarget.6994
Qin, N., Yagel, S., Momplaisir, M. L., Codd, E. E., and D’andrea, M. R. (2002).
Molecular cloning and characterization of the human voltage-gated calcium
channel alpha(2)delta-4 subunit. Mol. Pharmacol. 62, 485–496. doi: 10.1124/
mol.62.3.485
Rees, D. C., Thein, S. L., Osei, A., Drasar, E., Tewari, S., Hannemann, A.,
et al. (2015). The clinical significance of K-Cl cotransport activity in red cells
of patients with HbSC disease. Haematologica 100, 595–600. doi: 10.3324/
haematol.2014.120402
Rocha-Gonzalez, H. I., Mao, S., and Alvarez-Leefmans, F. J. (2008). Na+,K+,2Cl-
cotransport and intracellular chloride regulation in rat primary sensory
neurons: thermodynamic and kinetic aspects. J. Neurophysiol. 100, 169–184.
doi: 10.1152/jn.01007.2007
Rolver, M. G., Elingaard-Larsen, L. O., Andersen, A. P., Counillon, L., and
Pedersen, S. F. (2020). Pyrazine ring-based Na(+)/H(+) exchanger (NHE)
inhibitors potently inhibit cancer cell growth in 3D culture, independent of
NHE1. Sci. Rep. 10:5800.
Russell, J. M. (2000). Sodium-potassium-chloride cotransport. Physiol. Rev. 80,
211–276. doi: 10.1152/physrev.2000.80.1.211
Santoni, G., and Farfariello, V. (2011). TRP channels and cancer: new targets for
diagnosis and chemotherapy. Endocr. Metab. Immune Disord. Drug Targets 11,
54–67. doi: 10.2174/187153011794982068
Seo, Y., Lee, H. K., Park, J., Jeon, D. K., Jo, S., Jo, M., et al. (2016). Ani9, a novel
potent small-molecule ANO1 inhibitor with negligible effect on ANO2. PLoS
One 11:e0155771. doi: 10.1371/journal.pone.0155771
Seo, Y., Ryu, K., Park, J., Jeon, D. K., Jo, S., Lee, H. K., et al. (2017). Inhibition
of ANO1 by luteolin and its cytotoxicity in human prostate cancer PC-3 cells.
PLoS One 12:e0174935. doi: 10.1371/journal.pone.0174935
Shallat, S., Schmidt, L., Reaka, A., Rao, D., Chang, E. B., Rao, M. C., et al.
(1995). NHE-1 isoform of the Na+/H+ antiport is expressed in the rat
and rabbit esophagus. Gastroenterology 109, 1421–1428. doi: 10.1016/0016-
5085(95)90626-6
Shang, L., Hao, J. J., Zhao, X. K., He, J. Z., Shi, Z. Z., Liu, H. J., et al. (2016).
ANO1 protein as a potential biomarker for esophageal cancer prognosis and
precancerous lesion development prediction. Oncotarget 7, 24374–24382. doi:
10.18632/oncotarget.8223
Shapiro, J., Van Lanschot, J. J. B., Hulshof, M., Van Hagen, P., Van Berge, M. I.,
Wijnhoven, B. P. L., et al. (2015). Neoadjuvant chemoradiotherapy plus surgery
versus surgery alone for oesophageal or junctional cancer (CROSS): long-term
results of a randomised controlled trial. Lancet Oncol. 16, 1090–1098.
Shi, J., Mori, E., Mori, Y., Mori, M., Li, J., Ito, Y., et al. (2004). Multiple regulation by
calcium of murine homologues of transient receptor potential proteins TRPC6
and TRPC7 expressed in HEK293 cells. J. Physiol. 561, 415–432.
Shi, Y., Ding, X., He, Z. H., Zhou, K. C., Wang, Q., and Wang, Y. Z. (2009). Critical
role of TRPC6 channels in G2 phase transition and the development of human
oesophageal cancer. Gut 58, 1443–1450. doi: 10.1136/gut.2009.181735
Shikano, M., Ueda, T., Kamiya, T., Ishida, Y., Yamada, T., Mizushima, T., et al.
(2011). Acid inhibits TRPV4-mediated Ca(2)(+) influx in mouse esophageal
epithelial cells. Neurogastroenterol. Motil. 23, 1020–1028, e1497.
Shimizu, H., Shiozaki, A., Ichikawa, D., Fujiwara, H., Konishi, H., Ishii, H., et al.
(2014). The expression and role of Aquaporin 5 in esophageal squamous cell
carcinoma. J. Gastroenterol. 49, 655–666.
Shiozaki, A., Hikami, S., Ichikawa, D., Kosuga, T., Shimizu, H., Kudou, M., et al.
(2018). Anion exchanger 2 suppresses cellular movement and has prognostic
significance in esophageal squamous cell carcinoma. Oncotarget 9, 25993–
26006. doi: 10.18632/oncotarget.25417
Shiozaki, A., Kudou, M., Ichikawa, D., Shimizu, H., Arita, T., Kosuga, T., et al.
(2017). Expression and role of anion exchanger 1 in esophageal squamous cell
carcinoma. Oncotarget 8, 17921–17935. doi: 10.18632/oncotarget.14900
Shiozaki, A., Nako, Y., Ichikawa, D., Konishi, H., Komatsu, S., Kubota, T.,
et al. (2014a). Role of the Na (+)/K (+)/2Cl(-) cotransporter NKCC1 in cell
Frontiers in Physiology | www.frontiersin.org 14 July 2020 | Volume 11 | Article 855
fphys-11-00855 July 16, 2020 Time: 11:16 # 15
Becskeházi et al. Ion Transport in the Osophagus
cycle progression in human esophageal squamous cell carcinoma. World J.
Gastroenterol. 20, 6844–6859.
Shiozaki, A., Takemoto, K., Ichikawa, D., Fujiwara, H., Konishi, H., Kosuga, T.,
et al. (2014b). The K-Cl cotransporter KCC3 as an independent prognostic
factor in human esophageal squamous cell carcinoma. Biomed Res. Int.
2014:936401.
Siddique, I., and Khan, I. (2003). Regulation of Na/H exchanger-1 in
gastroesophageal reflux disease: possible interaction of histamine receptor. Dig.
Dis. Sci. 48, 1832–1838.
Silva, R. O., Bingana, R. D., Sales, T., Moreira, R. L. R., Costa, D. V. S., Sales,
K. M. O., et al. (2018). Role of TRPV1 receptor in inflammation and impairment
of esophageal mucosal integrity in a murine model of nonerosive reflux disease.
Neurogastroenterol. Motil. e13340. doi: 10.1111/nmo.13340 [Epub ahead of
print].
Slepkov, E. R., Rainey, J. K., Sykes, B. D., and Fliegel, L. (2007). Structural and
functional analysis of the Na+/H+ exchanger. Biochem. J. 401, 623–633. doi:
10.1042/bj20061062
Snow, J. C., Goldstein, J. L., Schmidt, L. N., Lisitza, P., and Layden, T. J. (1993).
Rabbit esophageal cells show regulatory volume decrease: ionic basis and effect
of pH. Gastroenterology 105, 102–110. doi: 10.1016/0016-5085(93)90015-5
Song, Y., Gao, J., Guan, L., Chen, X., Gao, J., and Wang, K. (2018). Inhibition
of ANO1/TMEM16A induces apoptosis in human prostate carcinoma cells by
activating TNF-alpha signaling. Cell Death Dis. 9:703.
Spechler, S. J., and Souza, R. F. (2014). Barrett’s esophagus. N. Engl. J. Med. 371,
836–845.
Stock, C., and Schwab, A. (2015). Ion channels and transporters in metastasis.
Biochim. Biophys. Acta 1848, 2638–2646. doi: 10.1016/j.bbamem.2014.11.012
Suzuki, N., Mihara, H., Nishizono, H., Tominaga, M., and Sugiyama, T.
(2015). Protease-activated receptor-2 Up-Regulates transient receptor potential
vanilloid 4 function in mouse esophageal Keratinocyte. Dig. Dis. Sci. 60, 3570–
3578. doi: 10.1007/s10620-015-3822-6
Tobey, N. A., Cragoe, E. J., and Orlando, R. C. (1995). HCl-induced cell edema in
rabbit esophageal epithelium: a bumetanide-sensitive process. Gastroenterology
109, 414–421. doi: 10.1016/0016-5085(95)90328-3
Tobey, N. A., Koves, G., and Orlando, R. C. (1998). Human esophageal epithelial
cells possess an Na+/H+ exchanger for H+ extrusion. Am. J. Gastroenterol. 93,
2075–2081. doi: 10.1111/j.1572-0241.1998.00596.x
Tobey, N. A., Reddy, S. P., Khalbuss, W. E., Silvers, S. M., Cragoe, E. J.,
and Orlando, R. C. (1993). Na(+)-dependent and -independent Cl-/HCO3-
exchangers in cultured rabbit esophageal epithelial cells. Gastroenterology 104,
185–195. doi: 10.1016/0016-5085(93)90851-3
Toth-Molnar, E., Venglovecz, V., Ozsvari, B., Rakonczay, Z., Varro, A., Papp, J. G.,
et al. (2007). New experimental method to study acid/base transporters and
their regulation in lacrimal gland ductal epithelia. Invest. Ophthalmol. Vis. Sci.
48, 3746–3755.
Tradtrantip, L., Zhang, H., Saadoun, S., Phuan, P. W., Lam, C., Papadopoulos,
M. C., et al. (2012). Anti-aquaporin-4 monoclonal antibody blocker therapy
for neuromyelitis optica. Ann. Neurol. 71, 314–322. doi: 10.1002/ana.
22657
Ueda, T., Shikano, M., Kamiya, T., Joh, T., and Ugawa, S. (2011). The TRPV4
channel is a novel regulator of intracellular Ca2+ in human esophageal
epithelial cells. Am. J. Physiol. Gastrointest. Liver Physiol. 301, G138–G147.
Vanoni, S., Zeng, C., Marella, S., Uddin, J., Wu, D., Arora, K., et al. (2020).
Identification of anoctamin 1 (ANO1) as a key driver of esophageal epithelial
proliferation in eosinophilic esophagitis. J. Allergy Clin. Immunol. 145, 239–
254.e2. doi: 10.1016/j.jaci.2019.07.049
Vashisht, A., Trebak, M., and Motiani, R. K. (2015). STIM and Orai proteins
as novel targets for cancer therapy. A review in the theme: cell and
molecular processes in cancer metastasis. Am. J. Physiol. Cell Physiol 309,
C457–C469.
Venglovecz, V., Hegyi, P., Rakonczay, Z., Tiszlavicz, L., Nardi, A., Grunnet,
M., et al. (2011). Pathophysiological relevance of apical large-conductance
Ca(2)+-activated potassium channels in pancreatic duct epithelial cells. Gut 60,
361–369. doi: 10.1136/gut.2010.214213
Venglovecz, V., Rakonczay, Z., Ozsvari, B., Takacs, T., Lonovics, J., Varro, A., et al.
(2008). Effects of bile acids on pancreatic ductal bicarbonate secretion in guinea
pig. Gut 57, 1102–1112. doi: 10.1136/gut.2007.134361
Walker, D., and De Waard, M. (1998). Subunit interaction sites in voltage-
dependent Ca2+ channels: role in channel function. Trends Neurosci. 21,
148–154. doi: 10.1016/s0166-2236(97)01200-9
Wanajo, A., Sasaki, A., Nagasaki, H., Shimada, S., Otsubo, T., Owaki, S., et al.
(2008). Methylation of the calcium channel-related gene, CACNA2D3, is
frequent and a poor prognostic factor in gastric cancer. . Gastroenterology 135,
580–590.
Wu, W., Dong, M. Q., Wu, X. G., Sun, H. Y., Tse, H. F., Lau, C. P., et al. (2012).
Human ether-a-go-go gene potassium channels are regulated by EGFR tyrosine
kinase. Biochim. Biophys. Acta 1823, 282–289. doi: 10.1016/j.bbamcr.2011.10.
010
Wulamu, W., Yisireyili, M., Aili, A., Takeshita, K., Alimujiang, A., Aipire, A.,
et al. (2019). Chronic stress augments esophageal inflammation, and alters
the expression of transient receptor potential vanilloid 1 and proteaseactivated
receptor 2 in a murine model. Mol. Med. Rep. 19, 5386–5396.
Xue, H., Wang, Y., Maccormack, T. J., Lutes, T., Rice, C., Davey, M., et al. (2018).
Inhibition of Transient Receptor Potential Vanilloid 6 channel, elevated in
human ovarian cancers, reduces tumour growth in a xenograft model. J. Cancer
9, 3196–3207. doi: 10.7150/jca.20639
Yamazato, Y., Shiozaki, A., Ichikawa, D., Kosuga, T., Shoda, K., Arita, T.,
et al. (2018). Aquaporin 1 suppresses apoptosis and affects prognosis in
esophageal squamous cell carcinoma. Oncotarget 9, 29957–29974. doi: 10.
18632/oncotarget.25722
Yu, X., Yu, M., Liu, Y., and Yu, S. (2016). TRP channel functions in the
gastrointestinal tract. Semin. Immunopathol. 38, 385–396. doi: 10.1007/s00281-
015-0528-y
Zeng, C., Vanoni, S., Wu, D., Caldwell, J. M., Wheeler, J. C., Arora, K., et al. (2018).
Solute carrier family 9, subfamily A, member 3 (SLC9A3)/sodium-hydrogen
exchanger member 3 (NHE3) dysregulation and dilated intercellular spaces in
patients with eosinophilic esophagitis. J. Allergy Clin. Immunol. 142, 1843–1855.
doi: 10.1016/j.jaci.2018.03.017
Zhang, D. Y., Wang, Y., Lau, C. P., Tse, H. F., and Li, G. R. (2008). Both EGFR
kinase and Src-related tyrosine kinases regulate human ether-a-go-go-related
gene potassium channels. Cell. Signal. 20, 1815–1821. doi: 10.1016/j.cellsig.
2008.06.006
Zhang, S. S., Wen, J., Yang, F., Cai, X. L., Yang, H., Luo, K. J., et al. (2013). High
expression of transient potential receptor C6 correlated with poor prognosis in
patients with esophageal squamous cell carcinoma. Med. Oncol. 30:607.
Zhang, Y., Zhang, Y., Fan, H., Shi, Y., Zhan, C., and Wang, Q. (2017). Study on
the role of transient receptor potential C6 channels in esophageal squamous
cell carcinoma radiosensitivity. J. Thorac. Dis. 9, 3802–3809. doi: 10.21037/jtd.
2017.09.108
Zhang, Z., Wu, X., Zhang, L., Mao, A., Ma, X., and He, D. (2020). Menthol relieves
acid reflux inflammation by regulating TRPV1 in esophageal epithelial cells.
Biochem. Biophys. Res. Commun. 525, 113–120. doi: 10.1016/j.bbrc.2020.02.050
Zhu, H., Zhang, H., Jin, F., Fang, M., Huang, M., Yang, C. S., et al. (2014). Elevated
Orai1 expression mediates tumor-promoting intracellular Ca2+ oscillations in
human esophageal squamous cell carcinoma. Oncotarget 5, 3455–3471. doi:
10.18632/oncotarget.1903
Conflict of Interest: The authors declare that the research was conducted in the
absence of any commercial or financial relationships that could be construed as a
potential conflict of interest.
Copyright © 2020 Becskeházi, Korsós, Ero˝ss, Hegyi and Venglovecz. This is an open-
access article distributed under the terms of the Creative Commons Attribution
License (CC BY). The use, distribution or reproduction in other forums is permitted,
provided the original author(s) and the copyright owner(s) are credited and that the
original publication in this journal is cited, in accordance with accepted academic
practice. No use, distribution or reproduction is permitted which does not comply
with these terms.
Frontiers in Physiology | www.frontiersin.org 15 July 2020 | Volume 11 | Article 855
